Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for China Cord Blood Corporation (CO : NYSE)
 
 • Company Description   
Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China.

Number of Employees: 1,260

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.68 Daily Weekly Monthly
20 Day Moving Average: 258,515 shares
Shares Outstanding: 121.55 (millions)
Market Capitalization: $325.76 (millions)
Beta: 0.39
52 Week High: $6.31
52 Week Low: $2.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.53% -18.77%
12 Week -35.73% -30.79%
Year To Date -36.04% -22.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD
-
HONG KONG,K3 -
CHN
ph: 852-3605-8180
fax: 852-3605-8181
ir@globalcordbloodcorp.com http://www.globalcordbloodcorp.com
 
 • General Corporate Information   
Officers
Ting Zheng - Chief Executive Officer and Chairman
Albert Chen - Chief Financial Officer
Mark D. Chen - Non-executive Director
Jennifer J. Weng - Non-executive Director
Jacky Cheng - Non-executive Director

Peer Information
China Cord Blood Corporation (CHCR)
China Cord Blood Corporation (ESRX)
China Cord Blood Corporation (MYDP)
China Cord Blood Corporation (GBCS)
China Cord Blood Corporation (LAXAF)
China Cord Blood Corporation (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G39342103
SIC: 8090
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 06/27/22
Share - Related Items
Shares Outstanding: 121.55
Most Recent Split Date: (:1)
Beta: 0.39
Market Capitalization: $325.76 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: -0.05
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 4.06
PEG Ratio: -
Price Ratios
Price/Book: 0.43
Price/Cash Flow: 3.83
Price / Sales: 1.68
EPS Growth
vs. Year Ago Period: 13.33%
vs. Previous Quarter: 6.25%
Sales Growth
vs. Year Ago Period: 11.69%
vs. Previous Quarter: 2.25%
ROE
03/31/22 - -
12/31/21 - 11.42
09/30/21 - 11.36
ROA
03/31/22 - -
12/31/21 - 6.42
09/30/21 - 6.34
Current Ratio
03/31/22 - -
12/31/21 - 10.65
09/30/21 - 10.22
Quick Ratio
03/31/22 - -
12/31/21 - 10.58
09/30/21 - 10.16
Operating Margin
03/31/22 - -
12/31/21 - 41.98
09/30/21 - 41.45
Net Margin
03/31/22 - -
12/31/21 - 41.98
09/30/21 - 41.45
Pre-Tax Margin
03/31/22 - -
12/31/21 - 52.77
09/30/21 - 52.31
Book Value
03/31/22 - -
12/31/21 - 6.18
09/30/21 - 5.94
Inventory Turnover
03/31/22 - -
12/31/21 - 4.72
09/30/21 - 4.40
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©